Description
The injectable gel Prostrolane Blanc B is indicated for whitening, toning, and providing radiance to the face as well as the neck. This product is a anti-pigmentation treatment with prolonged release.
Prostrolane Blanc B is indicated for the treatment of wrinkled skin aged by the sun and photoaging.
It is used in aesthetic medicine because it provides a peptide technology that brightens and tones the facial skin.
Targeted areas
- Whole face
- Pigmented zone (dark spot or melasma)
- Cou
Application Protocol
This product must be administered by authorized professionals.
- 1 session every 2 weeks:
If necessary, retouch after 2 months. - Injection volume: 0.05 ml to 0.2 ml per targeted points
- Volume per point: 0.02 – 0.05 cc
- Injection depth: 1mm/1.2mm
The Prostrolane Blanc B is injected notably with 32G – 1mm needles from Crystal Multineedle.
Count on 2 to 4 sessions on average..
Composition
Hyaluronic acid (0.7%), PBS (phosphate-buffered saline), Peptide complex (Oligopeptide-92, Octapeptide-11, Feruloyl Oligopeptide-33, Valprooyl Oligopeptide-33).
Processing Procedure
- Determine and clean the injection area (antiseptic solution). Use disposable gloves.
- Press the plunger carefully until a small drop is visible at the tip of the needle.
- Use a sterilized fine needle (27 G x 13 mm or 30 G x 13 mm) or Hycoox multi-needle injector.
- Place the needle parallel to the injection area (tilt it at an angle of 30 degrees) and insert it to a depth of approximately 0.8 mm.
- Inject White B under constant pressure by pressing on the piston. Stop the injection before the needle is withdrawn from the skin to avoid superficial application.
- Do not excessively correct the defect. It is necessary to be able to manually stretch the defect to the point of elimination in order to achieve the best results.
- If you are treating a localized task, inject into the area and then spread the rest of the product over the face to even out the skin.
- The degree and duration of the correction are adjustable according to the nature of the defect to be addressed.
- After the treatment, attach the traceability label to the patient’s medical file.
Expected results
- Inhibition of melanosome transfer
- Degradation activity of melanosome-lysosomes (DQ-BSA)
- Inhibition of melanin synthesis
- Inhibition of tyrosinase activity
- Look more radiant
- Skin rejuvenation
- Skin lightening
You must be logged in to post a review.
Reviews
There are no reviews yet.